Novocure Ltd
General ticker "NVCR" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.0B
Novocure Ltd follows the US Stock Market performance with the rate: 39.6%.
Estimated limits based on current volatility of 4.2%: low 30.33$, high 32.20$
Factors to consider:
- US accounted for 75.7% of revenue in the fiscal year ended 2022-12-31
- Current price 35.2% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [8.50$, 22.55$]
- 2024-12-30 to 2025-12-30 estimated range: [8.38$, 20.32$]
Financial Metrics affecting the NVCR estimates:
- Negative: Non-GAAP EPS, $ of -1.95 <= 0.10
- Negative: Operating profit margin, % of -31.38 <= 1.03
- Negative: Operating cash flow per share per price, % of -5.08 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0.04 <= 0.14
Short-term NVCR quotes
Long-term NVCR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $535.03MM | $537.84MM | $509.34MM |
| Operating Expenses | $579.36MM | $627.36MM | $742.21MM |
| Operating Income | $-44.33MM | $-89.52MM | $-232.87MM |
| Non-Operating Income | $-7.74MM | $7.68MM | $41.13MM |
| Interest Expense | $3.44MM | $3.33MM | $3.32MM |
| R&D Expense | $201.30MM | $206.09MM | $223.06MM |
| Income(Loss) | $-52.08MM | $-81.85MM | $-191.74MM |
| Taxes | $6.28MM | $10.69MM | $15.30MM |
| Profit(Loss) | $-58.35MM | $-92.53MM | $-207.04MM |
| Stockholders Equity | $410.49MM | $441.17MM | $362.50MM |
| Inventory | $24.43MM | $29.38MM | $38.15MM |
| Assets | $1,139.49MM | $1,191.65MM | $1,146.13MM |
| Operating Cash Flow | $82.76MM | $30.79MM | $-73.34MM |
| Capital expenditure | $24.17MM | $21.36MM | $27.09MM |
| Investing Cash Flow | $-144.83MM | $-139.96MM | $184.15MM |
| Financing Cash Flow | $25.70MM | $15.49MM | $15.79MM |
| Earnings Per Share* | $-0.56 | $-0.88 | $-1.95 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.